Minocycline-Induced Hyperpigmentation in a Patient Treated with Erlotinib for Non-Small Cell Lung Adenocarcinoma

INTRODUCTION: While epidermal growth factor receptor (EGFR) inhibitors have improved progression-free survival in patients with non-small cell lung cancer (NSCLC), one of the most common adverse effects is papulopustular skin eruption, which is frequently severe enough to be treated with oral minocy...

Descripción completa

Detalles Bibliográficos
Autores principales: Bell, Ann T., Roman, John W., Gratrix, Max L., Brzezniak, Christina E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346923/
https://www.ncbi.nlm.nih.gov/pubmed/28413391
http://dx.doi.org/10.1159/000452146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346923/
https://www.ncbi.nlm.nih.gov/pubmed/28413391
http://dx.doi.org/10.1159/000452146

Ejemplares similares